Cardinal Health gets downgraded to a hold, from my buy rating last February, agreeing with the Seeking Alpha quant system rating. While macro-level demand for medical supplies is expected to keep ...

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cardinal Health (CAH) is a stock that can certainly grab the ...

Cardinal Health Inc (CAH) stock saw a decline, ending the day at $127.73 which represents a decrease of $-3.00 or -2.29% from the prior close of $130.73. The stock opened at $130.84 and touched a low ...

Cardinal Health Inc. hit a new 52-week high, surpassing its previous peak of $129.68, which the company achieved on January ...

Dublin City Schools is withdrawing from an agreement to buy Cardinal Health’s headquarters for $37 million to serve as a high ...

2024 was packed with health care innovations, from a new blood test detecting Alzheimer’s disease to deep brain stimulation reversing paralysis. Heading into the New Year, medical experts are ...

The supply crunch follows a directive first issued on Tuesday by the acting director of the Department of Health and Human Services, which placed a moratorium on the release of any public ...

The Czech Health Ministry said supply ... that authorities have coordinated closely with medical facilities nationwide to maintain essential supplies. The State Institute for Drug Control reported ...